3
WSSCC approved to become the Sanitation and Hygiene Fund
plus
Actualités sur Medizin, Gesundheit
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Loures, Portugal (ots/PRNewswire) - Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020. Dr. Herbeaux held, over the past 20 years, multiple high-level leadership positions at Evonik, bringing to Hovione a proven commitment to develop a successful and globally active business. Based in Lisbon, ...
plusData From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
Darmstadt, Germany and New York (ots/PRNewswire) - - Not intended for US-, Canada- or UK-based media - ASCO Abstract # BAVENCIO® (avelumab): LBA1, 5061; Bintrafusp alfa (bifunctional fusion protein): 9558; Tepotinib (MET kinase inhibitor): 9556, 9575. - Late-breaking presentation of Phase III JAVELIN Bladder 100 data for BAVENCIO® showing overall survival benefit in ...
plusMental Health Care Company COMPASS Pathways Concludes Successful Series B Investment Round
London (ots/PRNewswire) - $80m Raised Will Further the Development of Psilocybin Therapy COMPASS Pathways, a mental health care company, announced today that it has completed a successful $80m Series B investment round. This funding will expand upon COMPASS's lead programme in psilocybin therapy for treatment-resistant depression, supporting research into additional ...
plusRB Statement: Improper Use of Disinfectants
Slough, England (ots/PRNewswire) - Due to recent speculation and social media activity, RB (the makers of Lysol and Dettol) has been asked whether internal administration of disinfectants may be appropriate for investigation or use as a treatment for coronavirus (SARS-CoV-2). As a global leader in health and hygiene products, we must be clear that under no circumstance should our disinfectant products be administered into ...
plusNew ClinicAll Communicator App Supports Care Staff vs Corona
New York (ots/PRNewswire) - Decisive action is now needed to fight the coronavirus successfully. Most importantly, nursing staff needs protection and support. Everything that makes their work easier improves patient care, relieves pressure on hospitals and, in the end, helps saving lives. That is why ClinicAll developed the new ClinicAll Communicator app. It connects patients and staff in the simplest way - digital, ...
plus
Zentiva and IKEA Joining Forces to Fight the COVID-19 Pandemic
Prague (ots/PRNewswire) - Zentiva Group, a.s. announces the agreement with IKEA to cooperate during the COVID-19 crisis. As part of this collaboration, Zentiva Romania will temporarily employ 18 employees from IKEA Romania for 3 months to sustain the production of medicines supply following the increasing demand. " At Zentiva we are doing everything in our power to help authorities fight COVID-19. Zentiva is working on ...
plusSOPHiA GENETICS Expands Its Executive Team, Naming Lara Hashimoto Chief Business Officer
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be responsible for Marketing, Product Management and Business Development. Lara Hashimoto joined the healthcare industry 20 years ago holding ...
plusAvectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office
Dublin (ots/PRNewswire) - Avectas announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,612,042, which is central to the company's cell engineering technology, Solupore® and expands Avectas' global Intellectual Property portfolio. This patent covers an approach for ...
plusZentiva Extends Commercial Footprint By Completing Acquisition of CEE Business From Alvogen
Prague (ots/PRNewswire) - Zentiva Group a.s. confirms the closing of its previously declared acquisition of Alvogen's Central and Eastern European (CEE) business. The deal adds to Zentiva's continuing organic growth, reinforcing Zentiva's commercial footprint in Poland, Romania and Bulgaria, and expanding its ...
plusCoping With the Coronavirus, Rambam Healthcare Campus in Israel Joins Forces With Elbit Systems to Deploy a Management & Control Technology
Haifa, Israel (ots/PRNewswire) - The Rambam Healthcare Campus ("Rambam") in Haifa, Israel starts operating EX-TEAMS, a cellular based management and control system that was jointly developed with Elbit Systems. EX-TEAMS is based on an Elbit Systems' Command & Control (C2) technology that was repurposed in recent ...
plusFirmenich Expands Hand Sanitizer Production; Donating 100 Tons Across USA and Switzerland
Geneva (ots/PRNewswire) - Building on Firmenich's donation of 20 tons of hand sanitizer in Geneva, the Group is increasing its production capacity to 100 tons for hospitals, as well as medical and emergency services across the USA and Switzerland. Firmenich has transformed its production lines to provide hand sanitizer vital to limiting the spread of COVID-19 and ...
plus
EU Commission wants to postpone MDR implementation by one year / Swiss Medtech considers the postponement essential to ensure patient care
Bern (ots) - In view of the coronavirus pandemic, Swiss Medtech considers the EU Commission proposal to postpone the Medical Devices Regulation (MDR) date of application by one year to be imperative. The Association hopes that the Council and Parliament will also promptly agree with the recommendation. Ensuring the ...
plusUCB Completes the Acquisition of Ra Pharmaceuticals - to Deliver Differentiated Therapies to Patients
Brussels (ots/PRNewswire) - - The transaction, which was announced October 10, 2019, will enhance UCB's potential to be a leader in myasthenia gravis by adding zilucoplan , a peptide inhibitor of complement component 5 (C5) currently in phase 3, to the UCB pipeline alongside rozanolixizumab , UCB's FcRn targeting ...
plusEW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions
Visbek, Germany (ots/PRNewswire) - Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as neonatal pig management, poultry ...
plusEW Nutrition launches industry-leading webinar series with topical Antimicrobial Resistance twin sessions
Visbek (ots) - Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as neonatal pig management, poultry gut health and many ...
plusSaxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® (liraglutide 3.0 mg) in adolescents (aged ...
plusPowertage 2020 being postponed
plus
FDA Grants Orphan Drug Designation to APR-OD031 for the Treatment of Phenylketonuria (PKU)
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research s.a. ("APR"), the Swiss pharma company leveraging drug delivery technologies to develop innovative products for niche and rare diseases, today announced that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for the Company's drug candidate APR-OD031 for the treatment ...
plusSOPHiA GENETICS and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic
Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering ...
plusNorgine B.V. Acquires Azanta A/S, Strengthening Its Position as a Leading European Specialist Pharmaceutical Company
Amsterdam (ots/PRNewswire) - Norgine B.V. ("Norgine") announces the acquisition of Azanta A/S, a specialty biopharmaceutical company operating within women's healthcare, addiction medicine and oncology. Azanta becomes a wholly-owned subsidiary of Norgine. To view the Multimedia News Release, please click: ...
plusEnghouse Vidyo Unit Helps Health Systems Scale Telemedicine To Mitigate Coronavirus Risk
Markham, Ontario (ots/PRNewswire) - Resilient Video Platform Ensures Health Systems Can Provide Remote Diagnoses and Effective Patient Care -Enghouse Systems Limited (TSX:ENGH) today announced its Vidyo, Inc. subsidiary has developed a program to help its telemedicine clients dramatically scale to combat the Coronavirus pandemic. The program allows for new or existing ...
plus- 2
FDI World Dental Federation: Global survey shows that less than half (38%) of parents limit their children´s sugary food and drink intake to ensure good oral health
plus Hitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe launches "ARIETTA 750", the new model from the ARIETTA series of diagnostic ultrasound platforms / This model inherited premium class technologies
plus
Carag First-ever Septal Occluder With Bioresorbable, Metal-free Framework Available to Patients Through New European Registry
Baar, Switzerland and Berlin (ots/PRNewswire) - First 3-year-old patient successfully implanted and discharged from hospital in Berlin CARAG AG, a Swiss privately held medical device development company, announced today the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, ...
plusSenzer Secures US Clinical Data Package for the Treatment of Chemotherapy Induced Adverse Events
London (ots/PRNewswire) - Senzer has secured the Investigational New Drug application and data package for its ongoing FDA registration programme from its former US strategic partner and will now push ahead to get its cannabinoid respiratory device approved for treating side effects induced by anti-cancer treatments ...
plusERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Darmstadt, Germany (ots/PRNewswire) - Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, ...
plusSOPHiA GENETICS' Board of Directors Elects Troy Cox as New Chairman
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020. He is replacing Antoine Duchateau, who has served as chairman since 2013 and will continue as a board member. Cox joined the ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Decision time predicts the risk of depression relapse
Bern (ots) - In a study supported by the Swiss National Science Foundation, researchers have shown that it is possible to predict the risk of relapsing into depression after stopping antidepressant medication. People who relapse take longer to decide how much effort to invest for a reward. Depressive disorder is a major public health problem with an unpredictable course. It often recurs, with episodes of depression ...
plusNew Data Show Oral Ferric Maltol (FERACCRU®) May Be a Cost-effective Alternative to Intravenous (IV) Carboxymaltose With at Least as Great Benefits in the Quality of Life of Patients With Iron Deficiency Anaemia and Inflammatory Bowel Disease
Amsterdam (ots/PRNewswire) - - Ferric maltol (FM) was associated with substantially lower use of healthcare resources than IV ferric carboxymaltose (FCM) - IV FCMwas linked to greater productivity loss and disruption to patients' work and family life due to the need for clinic-based IV administration - 50% of ...
plus
Précédent20212223242526272829Suivant